The study, led by the Barcelona Hospital Clinic, will be shortly published in the New England Journal of Medicine.
This was one of the conclusions of a scientific meeting, organised by the University Hospital of Navarra in Pamplona, which dealt with novelties in the systematic treatment of hepatocarcinoma. Doctor Ruth Vera García, Head of the Oncological Medicine Service at the Hospital of Navarra, Doctor Javier Bustamante Schneider of the Digestive System Service at Cruces Hospital in Bilbao and Doctors Mercedes Iñarrairaegui Bastarrica and Bruno Sangro Gómez-Acebo, both from the Hepatology Unit of the University Hospital of Navarra, presented novelties in the systematic treatment of hepatocarcinoma. The medics coincided in emphasising that the complexity of these patients, often suffering from hepatic cirrhosis also, means that the disorder has to be approached in a multidisciplinary manner and treated at centres which have all possible treatment resources available.
The fifth most common tumour
Hepatocarcinoma is the most frequent hepatic tumour, fifth in overall worldwide cancer rates and the third cause of cancer deaths in the world. In Spain, as in the rest of Mediterranean Europe, some 10 cases per one hundred thousand inhabitants appear every year – a rate of about 500 cases in Spain annually (50 in Navarre). In more than half the cases local curative treatment such as surgery, transplant or percutaneous ablation; or palliative ones, such as arterial embolisation or radioembolisation with radioactive spheres, can be applied.
In the rest of the cases, the prognosis is not good but, in the last five years, there have appeared more than ten pharmaceutical medicines known as biological agents or directed pharmaceutical drugs, the use of which in this tumour is currently being actively investigated, giving rise to a real hope for these patients.
Of these pharmaceutical medicines, Sorafenib has been the first to demonstrate its efficacy and the European Medicines Agency has recently authorised its use for this tumour, given that it can prolong patient survival at the cost of some side effects which, in 80% of cases, are manageable with a number of preventative or therapeutic measures.
Irati Kortabitarte | alfa
The genes are not to blame
20.07.2018 | Technische Universität München
Targeting headaches and tumors with nano-submarines
20.07.2018 | Universitätsmedizin der Johannes Gutenberg-Universität Mainz
A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.
The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...
For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.
To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...
For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.
Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...
Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.
A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...
Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.
"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....
13.07.2018 | Event News
12.07.2018 | Event News
03.07.2018 | Event News
20.07.2018 | Power and Electrical Engineering
20.07.2018 | Information Technology
20.07.2018 | Materials Sciences